Sangtae Park, M.D., M.P.H. is the Chief of Minimally Invasive Urology (Single Port Surgery) and is the Urologic Expert in the Minimally Invasive Surgical Training and Innovation Lab (MISTI) in the Department of Surgery at NorthShore University HealthSystem. His research and clinical interests include single port laparoscopic surgery, natural orifice (NOTES) urological surgery and robotic urological surgery. He uses these modalities to treat kidney, bladder, prostate cancers and benign conditions and is actively pursuing research to improve patient outcomes and surgical quality. Dr. Park is widely published in the medical literature, and serves on the review committee and editorial board of several leading urology journals. He has held professorships at distinguished medical centers such as the University of Washington, University of Chicago and served as a visiting professor at University of California, San Francisco, the Korean Urological Association and Interlaken, Switzerland.
MD, MPH, University of California, San Francisco School of Medicine, Graduated 1999
General Surgery, University of California, San Francisco School of Medicine, Graduated 2000
General Surgery, University of California, San Francisco, School of Medicine, graduated 2001
Urology, University of California, San Francisco, School of Medicine, graduated 2005
Minimally Invasive Urology, Endourology, University of Texas, Southwestern School of Medicine, Dallas, TX, graduated 2006
Urology, American Board of Urology, 2008
Additional Certifications of Specialty Qualifications
Professional Membership or Societies
American Urological Association
Chicago Urologic Society
North Central American Urological Association
Honors or Awards
Pfizer Visiting Professorship - University of Chicago, 2010
Pfizer Visiting Professorship - University of Washington, Seattle, WA, 2008
NIH Program Project Grant PO1 DK43881, 2007
Outstanding Laparoendoscopic Surgeon - The Society of Laparoendoscopic Surgeons, 2006
UCSF School of Medicine Resident Teaching Award, 2005
Pfizer Award for Distinction in Urology, 2005
Outstanding Laparoendoscopic Resident Surgeon Award, 2005
Best Poster - UCSF Joint Brain, Breast and Prostate Cancer SPORE meeting, 2004
Guest Speaker - International Urology Forum, Interlaken, Switzerland, 2007
Best Poster - Engineering and Urology Society meeting, Chicago, IL, 2009
Co-Chair, 2009 Korean World Urologic Congress, 2009
2007 Plenary Session Speaker, 2007 Korean Urological Association National Meeting, 2007
1. Yoon WJ, Brown, MA, Reinhall PG, Park S, Seibel EJ, Active Steering of a Custom Laser Scanning Cystoscope for Automated Bladder Surveillance. IEEE/ASME Transcations on Mechatronics, Feb 2010.
2. Yoon WJ, Park S, Reinhall PG, Seibel EJ, Development of an automated steering mechanism for bladder urothelium surveillance. American Society of Mechanical Engineering Journal of Medical Devices, 2009 Mar: 3(1):1-10.
3. Long L, Park S. Differences in patterns of care: reablation and nephrectomy rates after needle ablative therapy for renal masses stratified by medical specialty. J. Endourol. 2009 Mar; 23(3):421-6
4. Zeltser I, Dugi D, Gupta A, Park S, Kabbani W, Cadeddu J. Does topical haemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle? BJU Int. 2008 Sep;102(8):1005-7.
5. Zeltser IS, Gupta A, Bensalah K, Kabbani W, Jenkins A, Park S, Pearle MS, Cadeddu J. Focal radiofrequency coagulation-assisted laparoscopic partial nephrectomy: a novel nonischemic technique. J. Endourol. 2008 Jun;22(6):1269-73.
6. Tuncel A, Lucas S, Bensalah K, Zeltser IS, Jenkins A, Saeedi O, Park S, Cadeddu JA. A randomized comparison of conventional vs articulating laparoscopic needle-drivers for performing standardized suturing tasks by laparoscopy-naïve subjects. BJU Int. 2008 Mar;101(6):727-30.
7. Zeltser IS, Moonat S, Park S, Anderson JK, Cadeddu JA. Intermediate-term prospective results of radiofrequency-assisted laparoscopic partial nephrectomy: a non-ischaemic coagulative technique. BJU Int. 2008 Jan;101(1):36-8.
8. Park S, Pearle MS, Cadeddu JA, Lotan Y. Laparoscopic and open partial nephrectomy: cost comparison with analysis of individual parameters. J. Endourol. 2007 Dec;21(12):1449-54.
9. Shariat SF, Park S, Trinh QD, Roehrborn CG, Slawin KM, Karakiewicz PI. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms. J Urol. 2007 Oct;178(4):1229-37.
10. Long LO, Park S. Update on nephrolithiasis management. Minerva Urol Nefrol. 2007 Sep;59(3):317-25.
11. Park S, Pearle MS. Pathophysiology and management of calcium stones. Urol Clin North Am. 2007 Aug;34(3):323-34.
12. Stern JM, Stanfield J, Lotan Y, Park S, Hsieh JT, Cadeddu JA. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J Endourol. 2007 Aug;21(8):939-43.
13. Stern JM, Svatek R, Park S., Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007 Aug;100(2):287-90.
14. Park, S., Cadeddu, JA. Outcomes of radiofrequency ablation for kidney cancer. Cancer Control 2007 Jul;14(3):205-10.
15. Park S., Medical Management of urinary stone disease. Expert Opin Pharmacother. 2007 Jun;8(8): 1117-25.
16. Stern JM, Park S., Anderson JK, Landman J, Pearle M, Cadeddu JA. Functional assessment of crossing vessels as etiology of ureteropelvic junction obstruction. Urology. 2007 Jun;69(6):1022-4.
17. Duchene DA, Winfield HN, Cadeddu JA, Clayman RV, Gomella LG, Kavoussi LR, Mikhail AA, Park S., Permpongkosol S, Shalhav AL. Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology. 2007 Jun;69(6):1017-21.
18. Park S., Bergs R., Eberhart R., Baker L., Fernandez R., Cadeddu J.A. Trocar-less laparoscopy: Magnetic positioning of intra-abdominal camera and retractor. Annals of Surgery. 2007 March; 245(3):379-384.
19. Park S., Wians, F.H. and Cadeddu, J.A. Spurious prostate specific antigen (PSA) recurrence after radical prostatectomy: Interference by human anti-mouse heterophile antibodies. Int J Urol. 2007 Mar;14(3):251-253.
20. Stern, J.M., Yiee, J., Park S. Safety and efficacy of ureteral access sheaths. J Endourol. 2007 Feb;21(2):119-23.
21. Shariat SF, Roehrborn CG, Park S, McConnell JD, Alam N, Wheeler TM, Slawin KM. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J Clin Oncol. 2007 Feb 1;25(4):349-55.
22. Park S., Cadeddu J.A., Shingleton W.B. Oncologic Outcomes for Ablative Therapy for Kidney Cancer. Curr Urol Rep. 2007 Jan;8(1):31-7.
23. Park S., Jaffer O., Lotan Y., Saboorian, H., Roehrborn C.G., Cadeddu J.A. Contemporary laparoscopic and open radical retropubic prostatectomy: pathologic outcomes and Kattan postoperative nomograms are equivalent. Urology. 2007 Jan;69(1):118-22.
24. Park S., Strup S., Saboorian H., Cadeddu J.A. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens. Urology, 2006 Nov; 68(5):964-7.
25. Stern J.M., Anderson J.K., Lotan Y., Park S., Cadeddu J.A.. Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure? J Urol. 2006 Nov; 176(5):1969-72.
Sangtae Park, MD, MPH's contact info
Address & contact info:
1959 NE Pacific
Seattle, WA 98195
Every effort has been made to ensure the accuracy of the information in this directory. However some
changes may occur between updates. Please check with your provider to ensure that he or she
participates in your health plan.
WEDNESDAY, May 15 (HealthDay News) -- The U.S. Food and Drug Administration announced Wednesday that it has approved a drug to help men with advanced prostate cancer whose disease has spread to the bones.
The drug, Xofigo, is targeted to patients with late-stage, metastatic disease that h...Full Article
WEDNESDAY, May 8 (HealthDay News) -- Women suffering from recurring urinary tract infections may carry a particularly hearty strain of E. coli bacteria that flourishes in both the gut and the bladder, and can migrate back and forth despite repeated treatments, a small new study finds.
WEDNESDAY, May 8 (HealthDay News) -- Some diseases are especially tough to discuss.
When Tony Lee realized that his penis was curving whenever he had an erection -- making it painful and difficult for him to have sex -- he had no idea what was wrong. He became depressed and very worried, ...Full Article
TUESDAY, May 7 (HealthDay News) -- Men who are uninsured or underinsured get advanced prostate cancer at nearly four times the national average and don't survive as long as other men with advanced disease, a new study says.
"We've identified a group of advanced prostate cancer patients wh...Full Article
TUESDAY, May 7 (HealthDay News) -- If you're a man suffering from low energy or libido, the drug industry is eager to help. So-called "Low T" -- low testosterone -- has become a common catch phrase in TV commercials, and sales of testosterone supplements are on the rise in the United States.
TUESDAY, Jan. 22 (HealthDay News) -- U.S. Food and Drug Administration approval of Botox (onabotulinumtoxinA) has been expanded to include adults with overactive bladder who don't respond to a class of drugs called anticholinergics.
Overactive bladder's typical symptoms including leakage,...Full Article
All Content Posted on This Site is the Responsibility of the Party Posting Such Content. Participation on
This Site by a Party Does not Imply Endorsement of any Other Party’s Content, Products, or Services. Content
Should not be Used for Medical Advice, Diagnosis, or Treatment. see Additional Information.